Graft Versus Host Disease-Reduction Strategies
A Phase II Randomized Controlled Trial Comparing GVHD-Reduction Strategies for Allogeneic Peripheral Blood Transplantation (PBSCT) for Patients With Acute Leukemia or Myelodysplastic Syndrome: Selective Depletion of CD45RA+ Naïve T Cells (TND) vs. Post-Transplantation Cyclophosphamide (PTCy)
Arms / Cohorts
Experimental, Arm A1:Total Body Irradiation Based
Accepting patients
Experimental, Arm A2:Busulfan Based
Accepting patients
Experimental, Arm C1:TBI, PTCy, tacrolimus)
Accepting patients
Experimental, Arm C2:Busulfan, PTCy, tacrolimus)
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.